ART Fertility Clinics LLC
53
18
19
17
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
High Risk
Score: 60/100
13.2%
7 terminated/withdrawn out of 53 trials
70.8%
-15.7% vs industry average
0%
0 trials in Phase 3/4
0%
0 of 17 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (53)
Comparison of Two Types of Calcium (Ca²⁺) Ionophore Treatments for Oocyte Activation in Cases of Suboptimal Fertilization Potential
Role: lead
Impact of Dry vs Humidified Culture Conditions on Blastocyst Development and Aneuploidy: A Time-lapse Sibling Oocyte Study
Role: lead
Is the Diurnal Variation in Circulating Levels of Cortisol Reflected in Follicular Fluid of Preovulatory Follicles Close to Ovulation?
Role: lead
Is the AMH Intrafollicular Level a Predictor of the Ploidy Status of the Blastocyst?
Role: lead
Evaluating the Utility of Implementing Microfluids for Sperm Preparation Compared to Conventional Method of Density Gradient Centrifugation in a PGT-A Program: a Sibling Oocyte Study
Role: lead
Comparing IVF/ICSI Cycle Outcomes of Post Ovulation Ovarian Stimulation Protocol With Elonva Without GnRH Antagonist to Follicular Phase Day 2 Stimulation Fixed Day 5 Antagonist Protocol
Role: lead
Virtual Reality for Mindfulness and Anxiety Reduction in Fertility Procedures
Role: lead
Does Recombinant FSH (rFSH, i.g. Gonal F®) as Compared to Human Menopausal Gonadotrophin (hMG) Affect Telomere Length of Cumulus Cells During Antral Follicle Growth and Impact Blastocyst Status?
Role: lead
Whole-Brain Dynamics in the Natural Menstrual Cycle vs. an Ovarian Stimulated Cycle: Impact of Hormonal Fluctuations on Healthy Women Undergoing Ovarian Stimulation
Role: lead
Follicular Volume at the Time of Final Oocyte Maturation in Poor Responders, and Its Correlation With Oocyte Maturity
Role: lead
Hyaluronan-enriched Medium and Euploid Blastocyst Transfers
Role: lead
Serum FSH Monitoring for Identification of an Optimal Range During Ovarian Stimulation
Role: lead
Effect of Antioxydant-enriched Media on Blastocyst Euploidy Rates.
Role: lead
Optimal Timing of Euploid Day 6 Blastocyst Transfer in Frozen HRT Cycles, Day 6 or Day 7 of Progesterone Administration.
Role: lead
Descriptive Analysis of Serum Immunological Markers During an Euploid Frozen Embryo Transfer in a Natural Cycle.
Role: lead
Relaxin Measurement in Different Endometrial Preparation Approaches for Frozen Embryo Transfer
Role: lead
Is Decreased Ovarian Reserve Related to an Increased Number of Previous Early Miscarriages?
Role: lead
Will Autologous Platelet Rich Plasma Able To Restore Ovarian Function?
Role: lead
Is There A Role For Mechanical Stimulation In Ovarian Follicular Activation?
Role: lead
Development of a Screening Tool for Difficult Embryo Transfers
Role: lead